Two Epstein-Barr virus (EBV)–based testing approaches have shown promise for early detection of nasopharyngeal carcinoma (NPC). Neither has been independently validated nor their performance compared.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Full-year 2026 guidance assumes a stronger second half, driven by the productivity of 100 newly hired account executives and ...

Flow Space chatted with the CEO about why eliminating cervical cancer in the U.S. is closer to becoming reality.

The American College of Obstetricians and Gynecologists (ACOG) has updated its breast cancer screening guidelines, recommending that individuals at an average risk for breast cancer initiate ...

Medicare Part B covers one annual lung cancer screening via a low dose CT scan. But you must qualify based on recently expanded criteria. Your lung cancer screening may be covered by Medicare Part B, ...